|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
humans
other animals
|
|
gptkbp:annualCasesWorldwide
|
over 200 million
|
|
gptkbp:annualDeathsWorldwide
|
over 400,000
|
|
gptkbp:antibioticResistance
|
increasing concern
|
|
gptkbp:canBeFatal
|
yes
|
|
gptkbp:causedBy
|
gptkb:Plasmodium_knowlesi
gptkb:Plasmodium_malariae
gptkb:Plasmodium_ovale
gptkb:Plasmodium_vivax
gptkb:Plasmodium_falciparum
Plasmodium parasite
|
|
gptkbp:commonIn
|
gptkb:Central_America
gptkb:South_America
gptkb:South_Asia
gptkb:Southeast_Asia
gptkb:sub-Saharan_Africa
|
|
gptkbp:complication
|
gptkb:anemia
death
low birth weight
organ failure
cerebral malaria
|
|
gptkbp:diagnosedBy
|
blood smear microscopy
rapid diagnostic test
|
|
gptkbp:firstDescribed
|
gptkb:Charles_Louis_Alphonse_Laveran
1880
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Malaria
|
|
gptkbp:incubationPeriod
|
7-30 days
|
|
gptkbp:prevention
|
antimalarial drugs
indoor residual spraying
insecticide-treated bed nets
|
|
gptkbp:publicHealthConcern
|
high
|
|
gptkbp:symptom
|
fever
nausea
vomiting
headache
muscle pain
sweating
chills
|
|
gptkbp:transmissionSeason
|
rainy season
|
|
gptkbp:transmittedBy
|
gptkb:Anopheles_mosquito
|
|
gptkbp:treatment
|
quinine
artemisinin-based combination therapy
chloroquine
|
|
gptkbp:vaccineAvailable
|
yes
|
|
gptkbp:vaccineType
|
gptkb:RTS,S/AS01
|
|
gptkbp:vectorFor
|
important
|
|
gptkbp:WHOpriority
|
yes
|
|
gptkbp:bfsParent
|
gptkb:human
|
|
gptkbp:bfsLayer
|
3
|